ClinVar Miner

Submissions for variant NM_000410.4(HFE):c.175G>A (p.Val59Met)

gnomAD frequency: 0.00004  dbSNP: rs111033557
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Mendelics RCV000987659 SCV001137060 uncertain significance Hemochromatosis type 1 2019-05-28 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV003234881 SCV003934501 uncertain significance not specified 2023-05-04 criteria provided, single submitter clinical testing Variant summary: HFE c.175G>A (p.Val59Met) results in a conservative amino acid change located in the MHC class I-like antigen recognition-like domain (IPR011161) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 251490 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. In a cross-sectional review, c.175G>A has been reported in the literature as a non-informative genotype in a Caucasian control cohort (de Villiers_1999) or unclear reporting on detection despite inclusion within HFE gene mutation panels (example, Costa-Matos_2013, Sangiuolo_2015, Castiella_2016, Turkmen_2017, Schneeweiss-Gleixner_2021). These report(s) do not provide unequivocal conclusions about a penetrant association of the variant with Hemochromatosis Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26547814, 23657305, 25504993, 33791166, 28111930, 10401000). One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.
OMIM RCV000000033 SCV000020176 benign HFE POLYMORPHISM 1999-08-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.